19-4210089-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001393985.1(ANKRD24):c.902C>T(p.Ala301Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000093 in 1,612,462 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001393985.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD24 | NM_001393985.1 | c.902C>T | p.Ala301Val | missense_variant | 12/22 | ENST00000318934.9 | NP_001380914.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD24 | ENST00000318934.9 | c.902C>T | p.Ala301Val | missense_variant | 12/22 | 5 | NM_001393985.1 | ENSP00000321731 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152084Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000118 AC: 29AN: 245354Hom.: 0 AF XY: 0.000127 AC XY: 17AN XY: 133458
GnomAD4 exome AF: 0.0000938 AC: 137AN: 1460260Hom.: 0 Cov.: 33 AF XY: 0.000102 AC XY: 74AN XY: 726306
GnomAD4 genome AF: 0.0000854 AC: 13AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.0000807 AC XY: 6AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 30, 2024 | The c.902C>T (p.A301V) alteration is located in exon 12 (coding exon 11) of the ANKRD24 gene. This alteration results from a C to T substitution at nucleotide position 902, causing the alanine (A) at amino acid position 301 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at